Top Stories
Dallas Mavericks’ Exum to Miss Season After Urgent Knee Surgery
UPDATE: Dallas Mavericks guard Dante Exum will miss the entire 2023-2024 NBA season due to complications from his right knee that necessitate urgent surgery, the team confirmed today. This latest setback comes after Exum underwent summer surgery but was never cleared to practice, raising alarms about his recovery.
The Mavericks had re-signed Exum to a one-year, $3.3 million deal during the offseason, hoping to bolster their roster. However, his injury history has been a significant concern, with Exum averaging just 8.0 points and 2.8 assists over the past two seasons with Dallas.
In order to create an open roster spot, the Mavericks will need to waive Exum. However, due to the team being hard capped at the second apron of the salary cap, they won’t be able to sign a replacement player until January 6, 2024, according to ESPN’s Bobby Marks.
This latest development is a major blow to the Mavericks, who have been working to strengthen their team after a disappointing last season. Fans and analysts alike are reacting to the news, highlighting the impact of injuries on the franchise’s prospects for success.
As the situation unfolds, all eyes will be on the Mavericks’ front office to see how they will navigate the challenges presented by Exum’s absence. Stay tuned for updates on potential roster changes and the implications of this urgent situation for the team’s future.
-
Science1 month agoInventor Achieves Breakthrough with 2 Billion FPS Laser Video
-
Health2 months agoCommunity Unites for 7th Annual Into the Light Walk for Mental Health
-
Top Stories2 months agoCharlie Sheen’s New Romance: ‘Glowing’ with Younger Partner
-
Entertainment2 months agoDua Lipa Aces GCSE Spanish, Sparks Super Bowl Buzz with Fans
-
Entertainment2 months agoMother Fights to Reunite with Children After Kidnapping in New Drama
-
Top Stories1 month agoFormer Mozilla CMO Launches AI-Driven Cannabis Cocktail Brand Fast
-
Health2 months agoCurium Group, PeptiDream, and PDRadiopharma Launch Key Cancer Trial
-
Business2 months agoTyler Technologies Set to Reveal Q3 Earnings on October 22
-
World2 months agoIsrael Reopens Rafah Crossing After Hostage Remains Returned
-
World2 months agoR&B Icon D’Angelo Dies at 51, Leaving Lasting Legacy
-
Health2 months agoNorth Carolina’s Biotech Boom: Billions in New Investments
-
Entertainment2 months agoRed Sox’s Bregman to Become Free Agent; Tigers Commit to Skubal
